Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Reversal of apixaban and rivaroxaban...
Conference

Reversal of apixaban and rivaroxaban anticoagulation by andexanet alfa in ANNEXA-A&R as assessed by non-tissue factor (TF)-initiated thrombin generation independent of TF pathway inhibitor (TFPI)

Authors

Lu G; Lin J; Bronson M; Crowther M; Conley PB; Curnutte JT

Volume

39

Pagination

pp. 1050-1050

Publisher

OXFORD UNIV PRESS

Publication Date

August 1, 2018

Name of conference

European-Society-of-Cardiology Congress

Conference place

Munich, GERMANY

Conference start date

August 25, 2018

Conference end date

August 29, 2018

Conference proceedings

EUROPEAN HEART JOURNAL

ISSN

0195-668X